Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.

Norplant and contraceptive pricing : conflict of interest, protection of public ownership in drug development deals between tax-exempt, federally supported labs and the pharmaceutical industry : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session.

Saved in:
Bibliographic Details
Corporate Author: United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Technology
Format: Government Document Book
Language:English
Published: Washington : U.S. G.P.O., 1994-
Subjects:
Norgestrel > Prices > United States.
Contraceptives > Prices > United States.
Drugs > Research > United States.
Research and development contracts, Government > United States.
Research and development partnership > United States.
Medication.
Therapies.
Norgestrel > Prices.
Norgestrel.
Contraceptives > Prices.
Contraceptives.
Drugs > Research.
Drugs.
Research and development contracts, Government.
Research and development partnership.
United States.
Description
Item Description:Description based on pt. 3
Shipping list no.: 94-0103-P (pt. 3)
"Washington, DC, November 10, 1993"--Pt. 3
"Serial no. 103-59"--Pt. 3
Physical Description:volumes : illustrations, map ; 24 cm
Bibliography:Includes bibliographical references
ISBN:0160439124 (pt.3)

Similar Items